Epitranscriptomic regulation by m 6 A RNA methylation in mind growth and ailments
- Mobile RNAs are pervasively tagged with numerous chemical moieties, collectively known as epitranscriptomic modifications. The methylation of adenosine at N6place generates N6-methyladenosine (m6A), which is essentially the most ample and reversible epitranscriptomic modification in mammals.
- The m6A signaling is mediated by a devoted set of proteins comprised of writers, erasers, and readers. Opposite to the activation-repression binary view of gene regulation, rising proof means that the m6A methylation controls a number of elements of mRNA metabolism, akin to splicing, export, stability, translation, and degradation, culminating within the fine-tuning of gene expression.
- Mind exhibits the best abundance of m6A methylation within the physique, which is developmentally altered. Inside the mind, m6A methylation is biased towards neuronal transcripts and delicate to neuronal exercise. In a wholesome mind, m6A maintains a number of developmental and physiological processes akin to neurogenesis, axonal development, synaptic plasticity, circadian rhythm, cognitive perform, and stress response. The m6A imbalance contributes to the pathogenesis of acute and continual CNS insults, mind most cancers, and neuropsychiatric problems.
- This overview mentioned the molecular mechanisms of m6A regulation and its implication within the developmental, physiological, and pathological processes of the mind.

influenza-x
Gnas Complex Locus (GNAS) Antibody |
20-abx112824 |
Abbexa |
|
|
|
GNAS Complex Locus (GNAS) Antibody |
20-abx338380 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
GNAS antibody |
38452-100ul |
SAB |
100ul |
EUR 302.4 |
GNAS antibody |
70R-12940 |
Fitzgerald |
100 ul |
EUR 548.4 |
Description: Affinity purified Rabbit polyclonal GNAS antibody |
GNAS antibody |
70R-13520 |
Fitzgerald |
100 ul |
EUR 548.4 |
Description: Affinity purified Rabbit polyclonal GNAS antibody |
GNAS antibody |
70R-1643 |
Fitzgerald |
100 ug |
EUR 452.4 |
Description: Rabbit polyclonal GNAS antibody raised against the N terminal of GNAS |
GNAS antibody |
70R-1651 |
Fitzgerald |
100 ug |
EUR 452.4 |
Description: Rabbit polyclonal GNAS antibody raised against the C terminal of GNAS |
GNAS antibody |
70R-1652 |
Fitzgerald |
100 ug |
EUR 452.4 |
Description: Rabbit polyclonal GNAS antibody raised against the N terminal of GNAS |
GNAS antibody |
70R-21619 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal GNAS antibody |
GNAS antibody |
70R-5756 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal GNAS antibody raised against the N terminal of GNAS |
GNAS Antibody |
32899-100ul |
SAB |
100ul |
EUR 302.4 |
GNAS Antibody |
1-CSB-PA009596GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
GNAS Antibody |
1-CSB-PA147947 |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
GNAS Antibody |
1-CSB-PA247539 |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:1000, IHC:1:25-1:100 |
GNAS Antibody |
1-CSB-PA307619LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:200-1:500 |
GNAS Antibody |
1-CSB-PA352389LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
GNAS Antibody |
F40026-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The Gs protein is involved in hormonal regulation of adenylate cyclase: it activates the cyclase in response to beta-adrenergic stimuli. Alternative splicing of downstream exons of the GNAS gene is observed, which results in different forms of the stimulatory G protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants have been found for this gene, but the full-length nature and/or biological validity of some variants have not been determined. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. |
GNAS Antibody |
R35181-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: Guanine nucleotide binding protein alpha stimulating activity polypeptide 1 |
GNAS Antibody |
E92732 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
GNAS Antibody |
E91416 |
EnoGene |
100μg |
EUR 255 |
Description: Available in various conjugation types. |
GNAS Antibody |
E95546 |
EnoGene |
100μg |
EUR 255 |
Description: Available in various conjugation types. |
GNAS Antibody |
E10-30780 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Antibody |
E10-30780T |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Antibody |
E10-30781 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Antibody |
E10-30781T |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Antibody |
E19-7068 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Antibody |
E19-7388 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Complex Locus (GNAS) Antibody (HRP) |
20-abx337231 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
GNAS Complex Locus (GNAS) Antibody (FITC) |
20-abx337232 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
GNAS Complex Locus (GNAS) Antibody (Biotin) |
20-abx337233 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
anti- GNAS antibody |
FNab03536 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against GNAS |
GNAS Antibody (HRP) |
20-abx306647 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
GNAS Antibody (FITC) |
20-abx306648 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NESP55,GNAS Antibody |
abx235663-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
GNAS Antibody (Biotin) |
20-abx306649 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
GNAS complex locus (GNAS) polyclonal antibody |
ABP-PAB-11314 |
Allele Biotech |
100 ug |
Ask for price |
|
anti- NESP55,GNAS antibody |
FNab05663 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against NESP55,GNAS |
GNAS Antibody, HRP conjugated |
1-CSB-PA307619LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GNAS Antibody, HRP conjugated |
1-CSB-PA352389LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GNAS Antibody, FITC conjugated |
1-CSB-PA307619LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
GNAS Antibody, FITC conjugated |
1-CSB-PA352389LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
Polyclonal GNAS Antibody (Center) |
APR05815G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GNAS (Center). This antibody is tested and proven to work in the following applications: |
GNAS Antibody, Biotin conjugated |
1-CSB-PA307619LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
GNAS Antibody, Biotin conjugated |
1-CSB-PA352389LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against GNAS. Recognizes GNAS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
GNAS Conjugated Antibody |
C32899 |
SAB |
100ul |
EUR 476.4 |
GNAS Polyclonal Antibody |
A68803 |
EpiGentek |
-
EUR 754.26
-
Ask for price
-
Ask for price
-
EUR 470.80
|
- 100 ?g
- 20 ul
- 50 ul
- 100 ul
|
GNAS Polyclonal Antibody |
A64422 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Polyclonal GNAS Antibody (C-term) |
APR04328G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GNAS (C-term). This antibody is tested and proven to work in the following applications: |
Polyclonal GNAS Antibody (N-Term) |
AMM04827G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GNAS (N-Term). This antibody is tested and proven to work in the following applications: |
Monoclonal GNAS Antibody, Clone: 7G6G5 |
AMM03034G |
Leading Biology |
0.1ml |
EUR 633.6 |
Description: A Monoclonal antibody against Human GNAS. The antibodies are raised in Mouse and are from clone 7G6G5. This antibody is applicable in WB and IHC, FC, ICC, E |
Monoclonal GNAS Antibody, Clone: 2A2B7 |
AMM03035G |
Leading Biology |
0.1ml |
EUR 633.6 |
Description: A Monoclonal antibody against Human GNAS. The antibodies are raised in Mouse and are from clone 2A2B7. This antibody is applicable in WB and IHC, FC, ICC, E |
Polyclonal GNAS Antibody (aa385-394) |
APR02185G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GNAS (aa385-394). This antibody is tested and proven to work in the following applications: |
Polyclonal GNAS Antibody (internal region) |
APG00677G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human GNAS (internal region). This antibody is tested and proven to work in the following applications: |
GNAS Antibody (G protein alpha S) |
F40026-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The Gs protein is involved in hormonal regulation of adenylate cyclase: it activates the cyclase in response to beta-adrenergic stimuli. Alternative splicing of downstream exons of the GNAS gene is observed, which results in different forms of the stimulatory G protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants have been found for this gene, but the full-length nature and/or biological validity of some variants have not been determined. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. |
GNAS Polyclonal Antibody, HRP Conjugated |
A68804 |
EpiGentek |
-
EUR 754.26
-
EUR 293.70
-
EUR 470.80
|
|
GNAS Polyclonal Antibody, HRP Conjugated |
A64423 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
GNAS Polyclonal Antibody, FITC Conjugated |
A68805 |
EpiGentek |
-
EUR 754.26
-
EUR 293.70
-
EUR 470.80
|
|
GNAS Polyclonal Antibody, FITC Conjugated |
A64424 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
GNAS Polyclonal Antibody, Biotin Conjugated |
A68806 |
EpiGentek |
-
EUR 754.26
-
EUR 293.70
-
EUR 470.80
|
|
GNAS Polyclonal Antibody, Biotin Conjugated |
A64425 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
GNAS siRNA |
20-abx918154 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918155 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918156 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918157 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918158 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918159 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918160 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx918161 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx900009 |
Abbexa |
|
|
|
GNAS siRNA |
20-abx900030 |
Abbexa |
|
|
|
GNAS Peptide |
42-594P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: (IN) GNAS Peptide |
GNAS Mouse mAb |
E2221294 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Mouse mAb |
E2221295 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Mouse mAb |
E2221296 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Mouse mAb |
E2221297 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Rabbit pAb |
A2732-100ul |
Abclonal |
100 ul |
EUR 369.6 |
GNAS Rabbit pAb |
A2732-200ul |
Abclonal |
200 ul |
EUR 550.8 |
GNAS Rabbit pAb |
A2732-20ul |
Abclonal |
20 ul |
EUR 219.6 |
GNAS Rabbit pAb |
A2732-50ul |
Abclonal |
50 ul |
EUR 267.6 |
GNAS Rabbit pAb |
A5546-100ul |
Abclonal |
100 ul |
EUR 369.6 |
GNAS Rabbit pAb |
A5546-200ul |
Abclonal |
200 ul |
EUR 550.8 |
GNAS Rabbit pAb |
A5546-20ul |
Abclonal |
20 ul |
EUR 219.6 |
GNAS Rabbit pAb |
A5546-50ul |
Abclonal |
50 ul |
EUR 267.6 |
GNAS Rabbit pAb |
E2502732 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Rabbit pAb |
E2505546 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx233536-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx224154-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
20-abx141695 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 360.00
|
|
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx146570-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx146571-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx025004-100ul |
Abbexa |
100 ul |
EUR 627.6 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx025024-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx025024-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx030399-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx030399-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx016141-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx033029-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx033029-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
abx431295-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
20-abx002073 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
20-abx004246 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
20-abx141766 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 360.00
|
|
|
Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short (GNAS) Antibody |
20-abx306646 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
GNAS cloning plasmid |
CSB-CL009596HU1-10ug |
Cusabio |
10ug |
EUR 279.6 |
|
Description: A cloning plasmid for the GNAS gene. |
GNAS cloning plasmid |
CSB-CL009596HU2-10ug |
Cusabio |
10ug |
EUR 279.6 |
|
Description: A cloning plasmid for the GNAS gene. |
GNAS Blocking Peptide |
33R-9925 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GNAS antibody, catalog no. 70R-5756 |
GNAS Blocking Peptide |
33R-10097 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GNAS antibody, catalog no. 70R-1651 |
GNAS Blocking Peptide |
33R-8471 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GNAS antibody, catalog no. 70R-1652 |
GNAS Blocking Peptide |
33R-6814 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GNAS antibody, catalog no. 70R-1643 |
GNAS Blocking Peptide |
DF7068-BP |
Affbiotech |
1mg |
EUR 234 |
GNAS Blocking Peptide |
DF7388-BP |
Affbiotech |
1mg |
EUR 234 |
Recombinant human GNAS |
P1012 |
FN Test |
100ug |
Ask for price |
|
Description: Recombinant protein for human GNAS |
Rat GNAS shRNA Plasmid |
20-abx984695 |
Abbexa |
|
|
|
Rat GNAS shRNA Plasmid |
20-abx984696 |
Abbexa |
|
|
|
GNAS (Center) Rabbit pAb |
E2615919 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS Ascites Mouse mAb |
E2600105 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Human GNAS shRNA Plasmid |
20-abx951847 |
Abbexa |
|
|
|
Human GNAS shRNA Plasmid |
20-abx951848 |
Abbexa |
|
|
|
Human GNAS shRNA Plasmid |
20-abx951849 |
Abbexa |
|
|
|
Human GNAS shRNA Plasmid |
20-abx951850 |
Abbexa |
|
|
|
Mouse GNAS shRNA Plasmid |
20-abx970580 |
Abbexa |
|
|
|
Mouse GNAS shRNA Plasmid |
20-abx970581 |
Abbexa |
|
|
|
Mouse GNAS shRNA Plasmid |
20-abx970582 |
Abbexa |
|
|
|
Mouse GNAS shRNA Plasmid |
20-abx970583 |
Abbexa |
|
|
|
Gnas ORF Vector (Rat) (pORF) |
ORF067655 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Rat) (pORF) |
ORF067656 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Rat) (pORF) |
ORF067657 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Rat) (pORF) |
ORF067658 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Rat) (pORF) |
ORF067659 |
ABM |
1.0 ug DNA |
EUR 607.2 |
GNAS (N-Term) Rabbit pAb |
E2619438 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS (C-term) Rabbit pAb |
E2611017 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS (C-term) Rabbit pAb |
E2613945 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
GNAS ORF Vector (Human) (pORF) |
ORF004496 |
ABM |
1.0 ug DNA |
EUR 114 |
GNAS ORF Vector (Human) (pORF) |
ORF004497 |
ABM |
1.0 ug DNA |
EUR 114 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046308 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046309 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046310 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046311 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046312 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046313 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046314 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Gnas ORF Vector (Mouse) (pORF) |
ORF046315 |
ABM |
1.0 ug DNA |
EUR 607.2 |
GNAS ELISA Kit (Rat) (OKCA01910) |
OKCA01910 |
Aviva Systems Biology |
96 Wells |
EUR 1015.2 |
Description: Description of target: Guanine nucleotide-binding proteins (G proteins) function as transducers in numerous signaling pathways controlled by G protein-coupled receptors (GPCRs). Signaling involves the activation of adenylyl cyclases, resulting in increased levels of the signaling molecule cAMP. GNAS functions downstream of several GPCRs, including beta-adrenergic receptors. XLas isoforms interact with the same set of receptors as Gnas isoforms.;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 0.078 ng/mL |
GNAS ELISA Kit (Human) (OKCA01388) |
OKCA01388 |
Aviva Systems Biology |
96 Wells |
EUR 1015.2 |
Description: Description of target: ;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 0.078 ng/mL |
GNAS ELISA Kit (Human) (OKWB00174) |
OKWB00174 |
Aviva Systems Biology |
96 Wells |
EUR 686.4 |
Description: Description of target: Guanine nucleotide-binding proteins (G proteins) function as transducers in numerous signaling pathways controlled by G protein-coupled receptors (GPCRs). Signaling involves the activation of adenylyl cyclases, resulting in increased levels of the signaling molecule cAMP. GNAS functions downstream of several GPCRs, including beta-adrenergic receptors. Stimulates the Ras signaling pathway via RAPGEF2.;Species reactivity: Human;Application: ;Assay info: Assay Type: Quantitative Sandwich ELISA;Sensitivity: 46.9 nmol/mL |
GNAS ELISA Kit (Human) (OKEH08012) |
OKEH08012 |
Aviva Systems Biology |
96 Wells |
EUR 1075.2 |
Description: Description of target: This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.128ng/mL |
Human GNAS Protein Lysate 20ug |
IHUGNASPLLY20UG |
Innovative research |
each |
EUR 213 |
|
Description: Human GNAS Protein Lysate 20ug |
Anti-GNAS antibody |
STJ27492 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. |
Anti-GNAS antibody |
STJ23816 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. |
GNAS-AS1 ORF Vector (Human) (pORF) |
ORF020250 |
ABM |
1.0 ug DNA |
EUR 114 |
Gnas sgRNA CRISPR Lentivector set (Rat) |
K7535001 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Gnas 3'UTR GFP Stable Cell Line |
TU255211 |
ABM |
1.0 ml |
Ask for price |
Gnas 3'UTR GFP Stable Cell Line |
TU158852 |
ABM |
1.0 ml |
Ask for price |
GNAS 3'UTR GFP Stable Cell Line |
TU058977 |
ABM |
1.0 ml |
EUR 2799.6 |
GNAS sgRNA CRISPR Lentivector set (Human) |
K0875301 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Gnas sgRNA CRISPR Lentivector set (Mouse) |
K4363501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
GNAS Protein Vector (Rat) (pPM-C-HA) |
PV270620 |
ABM |
500 ng |
EUR 723.6 |
RNA-Binding Proteins in Most cancers: Practical and Therapeutic Views
RNA-binding proteins (RBPs) crucially regulate gene expression by post-transcriptional regulation, akin to by modulating microRNA (miRNA) processing and the choice splicing, different polyadenylation, subcellular localization, stability, and translation of RNAs. Greater than 1500 RBPs have been recognized so far, and plenty of of them are recognized to be deregulated in most cancers. Alterations within the expression and localization of RBPs can affect the expression ranges of oncogenes, tumor-suppressor genes, and genome stability-related genes.
RBP-mediated gene regulation can result in numerous cancer-related mobile phenotypes, akin to proliferation, apoptosis, angiogenesis, senescence, and epithelial-mesenchymal transition (EMT)/invasion/metastasis. This regulation can be related to most cancers prognosis.
Thus, RBPs could be potential targets for the event of therapeutics for the most cancers therapy. On this overview, we describe the molecular features of RBPs, their roles in cancer-related mobile phenotypes, and numerous approaches that could be used to focus on RBPs for most cancers therapy.
Circulating Lengthy Non-Coding RNA GAS5 Is Overexpressed in Serum from Osteoporotic Sufferers and Is Related to Elevated Danger of Bone Fragility
Osteoporosis (OP) is a multifactorial dysfunction through which environmental elements together with genetic variants and epigenetic mechanisms have been implicated. Lengthy non-coding RNAs (lncRNAs) have just lately emerged as essential regulators of bone metabolism and OP aetiology.
On this research, we analyzed the expression degree and the genetic affiliation of lncRNA GAS5 in OP sufferers in comparison with controls. Quantitative RT-PCR evaluation of GAS5 was carried out on the serum of 56 OP sufferers and 28 wholesome people. OP topics had been divided into three teams of research: 29 with fragility fractures of lumbar backbone (OP_VF), 14 with fragility fractures of femoral neck (OP_FF) and 13 with out fractures (OP_WF). Genotyping of the rs145204276 insertion/deletion polymorphism has additionally been carried out by Restriction fragment size polymorphism (RFLP) and direct sequencing analyses.
Expression of circulating GAS5 is considerably elevated in OP sufferers in comparison with controls (p < 0.01), with a statistically greater significance in fractured OP people vs. wholesome topics (p < 0.001). No statistically important change was present in feminine OP sufferers; conversely, GAS5 is upregulated within the subgroup of fractured OP ladies sera (p < 0.01) and in all OP males (p < 0.05). Moreover, a direct correlation between GAS5 expression degree and parathyroid hormone (PTH) focus was present in OP sufferers (r = 0.2930; p = 0.0389).
Genetic evaluation of rs145204276 revealed that the deletion allele was correlated with the next expression of GAS5 in OP sufferers (0.22 ± 0.02 vs. 0.15 ± 0.01, ** p < 0.01). Our outcomes recommend circulating GAS5 as a putative biomarker for the prognosis and prognosis of OP and OP-related fractures.
SOX2 Antibody |
31128-100ul |
SAB |
100ul |
EUR 302.4 |
SOX2 Antibody |
31128-50ul |
SAB |
50ul |
EUR 224.4 |
SOX2 antibody |
38134-100ul |
SAB |
100ul |
EUR 302.4 |
SOX2 Antibody |
43142-100ul |
SAB |
100ul |
EUR 302.4 |
Sox2 antibody |
70R-SR013 |
Fitzgerald |
100 ug |
EUR 360 |
Description: Affinity purified Rabbit polyclonal Sox2 antibody |
SOX2 Antibody |
5583-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SOX2 Antibody: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. SOX2 is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. The role of SOX2 in embryonic development suggested that it might be useful in the creation of stem cells that might be useful in cell replacement therapies in the treatment of degenerative diseases. Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing SOX2 and the transcription factors POU5F1, Klf4 and Lin28 along with c-Myc in mouse fibroblasts. Other experiments have shown that iPS cells could be generated using expression plasmids expressing POU5F1, SOX2, KlfF4 and c-Myc, eliminating the need for virus introduction. |
SOX2 Antibody |
5583-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SOX2 Antibody: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. SOX2 is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. The role of SOX2 in embryonic development suggested that it might be useful in the creation of stem cells that might be useful in cell replacement therapies in the treatment of degenerative diseases. Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing SOX2 and the transcription factors POU5F1, Klf4 and Lin28 along with c-Myc in mouse fibroblasts. Other experiments have shown that iPS cells could be generated using expression plasmids expressing POU5F1, SOX2, KlfF4 and c-Myc, eliminating the need for virus introduction. |
SOX2 antibody |
70R-12166 |
Fitzgerald |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal SOX2 antibody |
SOX2 antibody |
70R-33158 |
Fitzgerald |
100 ug |
EUR 522 |
Description: Rabbit polyclonal SOX2 antibody |
SOX2 antibody |
70R-33160 |
Fitzgerald |
100 ug |
EUR 522 |
Description: Rabbit polyclonal SOX2 antibody |
SOX2 antibody |
70R-20460 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal SOX2 antibody |
SOX2 Antibody |
48128-100ul |
SAB |
100ul |
EUR 399.6 |
SOX2 Antibody |
48128-50ul |
SAB |
50ul |
EUR 286.8 |
SOX2 Antibody |
1-CSB-PA16539A0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against SOX2. Recognizes SOX2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
SOX2 Antibody |
CSB-PA982860- |
Cusabio |
each |
EUR 402 |
|
Description: A polyclonal antibody against SOX2. Recognizes SOX2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
SOX2 Antibody |
CSB-PA982860-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against SOX2. Recognizes SOX2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
SOX2 Antibody |
1-CSB-PA022426GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against SOX2. Recognizes SOX2 from Human, Mouse, Rat, Zebrafish. This antibody is Unconjugated. Tested in the following application: ELISA, IF |
SOX2 Antibody |
1-CSB-PA588368 |
Cusabio |
|
|
|
Description: A polyclonal antibody against SOX2. Recognizes SOX2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:15-1:50 |
SOX2 Antibody |
1-CSB-PA698932 |
Cusabio |
|
|
|
Description: A polyclonal antibody against SOX2. Recognizes SOX2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
SOX2 Antibody |
F52893-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206. Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F52921-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F52921-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F52993-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F52993-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F53133-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206. Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F53133-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206. Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). |
SOX2 Antibody |
F54738-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. This protein may act as a transcriptional activator after forming a protein complex with other proteins. Mutations in the SOX2 gene have been associated with bilateral anophthalmia, a severe form of structural eye malformation. |
SOX2 Antibody |
F54738-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. This protein may act as a transcriptional activator after forming a protein complex with other proteins. Mutations in the SOX2 gene have been associated with bilateral anophthalmia, a severe form of structural eye malformation. |
SOX2 Antibody |
F40361-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (SOX2OT). |
SOX2 Antibody |
F40361-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 330.65 |
Description: This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (SOX2OT). |
SOX2 Antibody |
F47908-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: The intronless gene for SOX2 encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The encoded protein may act as a transcriptional activator after forming a protein complex with other proteins. Mutations in the SOX2 gene have been associated with bilateral anophthalmia, a severe form of structural eye malformation. |
SOX2 Antibody |
F47909-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. This protein may act as a transcriptional activator after forming a protein complex with other proteins. Mutations in the SOX2 gene have been associated with bilateral anophthalmia, a severe form of structural eye malformation. |
SOX2 Antibody |
F47909-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. This protein may act as a transcriptional activator after forming a protein complex with other proteins. Mutations in the SOX2 gene have been associated with bilateral anophthalmia, a severe form of structural eye malformation. |
SOX2 Antibody |
F49268-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. |
SOX2 Antibody |
F49268-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. |
SOX2 Antibody |
V7640-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation. [UniProt] |
SOX2 Antibody |
V7640-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation. [UniProt] |
SOX2 Antibody |
V7640SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation. [UniProt] |
SOX2 Antibody |
V7863-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V7863-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V7863SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V7864-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V7864-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V7864SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V8085-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V8085-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V8085SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V8086-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V8086-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
V8086SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. Reportedly, SOX2 is associated with aggressive phenotypes of breast, head and neck, gastric, colorectal, bladder, and small cell lung cancers. However, SOX2 is expressed in a high percentage of lung squamous cell carcinomas and has been shown to be an independent favorable prognostic marker. |
SOX2 Antibody |
R31408 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: SRY (sex determining region Y)-box 2 is a transcription factor that is essential for maintaining self-renewal, or pluripotency of undifferentiated embryonic stem cells. The protein is a member of the Sox family of transcription factors, which have been shown to play key roles in many stages of mammalian development. It was found that SOX2 can regulate OCT3/4 expression and maintains ES pluripotency through upstream transcription factors. It is identified as a lineage-survival oncogene in lung and esophageal squamous cell carcinoma. In addition to those, it has a critical role in maintenance of embryonic and neural stem cells and holds great promise in research involving induced pluripotency, an emerging and very promising field of regenerative medicine. |
SOX2 Antibody |
V3385-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3385-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3385IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3385SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3386-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3386-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3386IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
V3386SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. At present, 30 Sox genes have been identified. SOX2 is required for stem cell maintenance in the central nervous system, and it also regulates gene expression in the stomach. SOX2 is necessary for regulating multiple transcription factors that affect Oct 3/4 expression. An essential function of SOX2 is to stabilize embryonic stem cells in a pluripotent state by maintaining the requisite level of Oct 3/4 expression. |
SOX2 Antibody |
E021425 |
EnoGene |
50μg/50μl |
EUR 100 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E031128 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E043142 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E10-20267 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E10-30144 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
Sox2 Antibody |
E220095-1 |
EnoGene |
50μg/50μl |
EUR 145 |
Description: Available in various conjugation types. |
Sox2 Antibody |
E220095-2 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E220170-1 |
EnoGene |
50μg/50μl |
EUR 145 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E220170-2 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E301925 |
EnoGene |
200ul |
EUR 275 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E301926b |
EnoGene |
200ul |
EUR 275 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E561026-A-SE |
EnoGene |
100ug |
EUR 295 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E561028-A-SE |
EnoGene |
100ug |
EUR 295 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E18-4010-1 |
EnoGene |
50μg/50μl |
EUR 145 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E18-4010-2 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E18-5140-1 |
EnoGene |
50μg/50μl |
EUR 145 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E18-5140-2 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E19-6109 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E90561 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
SOX2 Antibody |
E81106-1 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC941791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF594 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC941791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF594 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC941792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF594 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC941792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF594 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC801791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF680 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC801791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF680 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC801792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF680 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC801792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF680 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC701791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF770 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC701791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF770 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC701792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF770 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC701792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF770 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC881791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF488A conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC881791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF488A conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC881792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF488A conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC881792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF488A conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC811791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF680R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC811791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF680R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC811792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF680R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC811792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF680R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC051791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF405M conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC051791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF405M conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC051792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF405M conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC051792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF405M conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC041791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF405S conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC041791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF405S conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC041792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF405S conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC041792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF405S conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC401791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF640R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC401791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF640R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC401792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF640R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC401792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF640R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCAP1791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCAP1791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCAP1792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCAP1792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCA1791-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),APC conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCA1792-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),APC conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCP1791-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),PerCP conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCP1792-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),PerCP conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCR1791-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),RPE conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCR1792-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),RPE conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCH1791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCH1791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCH1792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCH1792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCB1791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),Biotin conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNCB1791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),Biotin conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCB1792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),Biotin conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNCB1792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),Biotin conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNUB1792-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792), Concentration: 0.2mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNUB1791-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791), Concentration: 0.2mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNUB1791-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791), Concentration: 0.2mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNUB1792-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792), Concentration: 0.2mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNUM1791-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791), 1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNUM1792-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792), 1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC471791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF647 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC471791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF647 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC471792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF647 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC471792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF647 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC611791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF660R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC611791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF660R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC611792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF660R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC611792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF660R conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC431791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF543 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC431791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF543 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC431792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF543 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC431792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF543 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC551791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF555 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC551791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF555 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC551792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF555 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC551792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF555 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC681791-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF568 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1791) Antibody |
BNC681791-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1791),CF568 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC681792-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF568 conjugate, Concentration: 0.1mg/mL |
SOX2 (Transcription Factor) (SOX2/1792) Antibody |
BNC681792-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against SOX2 (Transcription Factor) (SOX2/1792),CF568 conjugate, Concentration: 0.1mg/mL |
anti- SOX2 antibody |
FNab08125 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against SOX2 |
anti- SOX2 antibody |
FNab08126 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against SOX2 |
anti- SOX2 antibody |
FNab10148 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against SOX2 |
Human SOX2 Antibody |
32612-05111 |
AssayPro |
150 ug |
EUR 313.2 |
Polyclonal SOX2 Antibody |
APR13481G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX2 . This antibody is tested and proven to work in the following applications: |
Polyclonal SOX2 Antibody |
APR13484G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX2 . This antibody is tested and proven to work in the following applications: |
Monoclonal Sox2 Antibody |
APR13485G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A Monoclonal antibody against Human Sox2. The antibodies are raised in Mouse. This antibody is applicable in WB, ICC, FC |
SOX2 (pS83) Antibody |
abx032060-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
SOX2 (pS83) Antibody |
abx032060-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Sox2 (pS249) Antibody |
abx032092-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Sox2 (pS249) Antibody |
abx032092-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Sox2 (pS251) Antibody |
abx032097-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Sox2 (pS251) Antibody |
abx032097-80l |
Abbexa |
80 µl |
EUR 343.2 |
|